Zhitong Finance App News, Sanyou Medical (688085.SH) announced that the company plans to acquire 37.1077% of the shares of Beijing Shuimu Tianpeng Medical Technology Co., Ltd. (“Mizuki Tianpeng”) held by Cao Qun and Xunong in total, and the Shanghai Yanzhan Enterprise Management Partnership (Limited Partnership) (“Shanghai Huanzhan”) (“Shanghai Huanzhan”) 98.9986% of the limited partner's investment share through the subsidiary Tuoteng (Suzhou) Medical Technology Co., Ltd. through cash acquisition of Zhanggang Tianpeng (“Mizuki Tianpeng”) hold Shanghai also anticipated 1.0014% of the general partner's share and issued shares to raise supporting capital (“this transaction”). The issue price for issuing shares to purchase assets is 13.18 yuan/share.
According to the announcement, Shanghai also sees itself as a shareholding platform for Mizuki Tianpeng employees, and has not carried out any other business other than holding shares in Mizuki Tianpeng. Prior to this transaction, the company held 51.8154% of Mizuki Tianpeng's shares; after the transaction is completed, the company will directly hold 88.9231% of Mizuki Tianpeng's shares, directly and through Tuoteng (Suzhou) Medical Technology Co., Ltd., and then indirectly hold 11.0769% of Mizuki Tianpeng's shares, controlling 100% of Mizuki Tianpeng's shares in total.
According to reports, Mizuki Tenpou is a medical device company focusing on R&D, production and sales of ultrasonic surgical equipment and consumables such as ultrasound bone cutters and ultrasonic hemostatic knives. It is a leader in ultrasonic energy surgery tools in China. The product uses cover many medical treatment fields such as orthopedics, spinal surgery, neurosurgery, orthopedic surgery, hand and foot surgery, urology, gynecology, and hepatobiliary surgery. Through this transaction, the company can further expand its investment in the field of clinical medical equipment for ultrasound surgery, which will facilitate the exchange of resource channels with Mizuki Tenpeng at various levels, such as customer resources, sales channels, and R&D technology.